Wells Fargo’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.25M Buy
89,639
+12,357
+16% +$173K ﹤0.01% 3224
2025
Q1
$1.05M Sell
77,282
-11,651
-13% -$158K ﹤0.01% 3234
2024
Q4
$1.81M Sell
88,933
-4,764
-5% -$97.1K ﹤0.01% 2871
2024
Q3
$2.73M Buy
93,697
+19,376
+26% +$564K ﹤0.01% 2545
2024
Q2
$1.73M Buy
74,321
+9,538
+15% +$221K ﹤0.01% 2821
2024
Q1
$1.33M Sell
64,783
-1,582
-2% -$32.5K ﹤0.01% 2957
2023
Q4
$1.42M Sell
66,365
-69,561
-51% -$1.49M ﹤0.01% 2881
2023
Q3
$2.8M Sell
135,926
-26,628
-16% -$549K ﹤0.01% 2363
2023
Q2
$4.8M Buy
162,554
+37,484
+30% +$1.11M ﹤0.01% 2072
2023
Q1
$2.88M Buy
125,070
+60,381
+93% +$1.39M ﹤0.01% 2407
2022
Q4
$1.8M Sell
64,689
-198
-0.3% -$5.51K ﹤0.01% 2700
2022
Q3
$1.99M Sell
64,887
-4,319
-6% -$133K ﹤0.01% 2589
2022
Q2
$2.04M Sell
69,206
-41,062
-37% -$1.21M ﹤0.01% 2628
2022
Q1
$3.55M Sell
110,268
-33,268
-23% -$1.07M ﹤0.01% 2606
2021
Q4
$6.4M Sell
143,536
-21,209
-13% -$946K ﹤0.01% 2192
2021
Q3
$8.31M Buy
164,745
+16,972
+11% +$856K ﹤0.01% 2291
2021
Q2
$11.6M Buy
147,773
+31,649
+27% +$2.48M ﹤0.01% 2048
2021
Q1
$6.63M Sell
116,124
-7,570
-6% -$432K ﹤0.01% 2453
2020
Q4
$10.4M Buy
123,694
+37,945
+44% +$3.18M ﹤0.01% 2042
2020
Q3
$3.07M Buy
85,749
+5,750
+7% +$206K ﹤0.01% 2929
2020
Q2
$1.94M Sell
79,999
-79,340
-50% -$1.92M ﹤0.01% 3229
2020
Q1
$2.79M Buy
159,339
+14,082
+10% +$247K ﹤0.01% 2682
2019
Q4
$2.53M Sell
145,257
-631
-0.4% -$11K ﹤0.01% 3127
2019
Q3
$2.24M Buy
145,888
+6,464
+5% +$99K ﹤0.01% 3197
2019
Q2
$2.9M Buy
139,424
+66,773
+92% +$1.39M ﹤0.01% 2999
2019
Q1
$1.69M Sell
72,651
-1,859
-2% -$43.2K ﹤0.01% 3469
2018
Q4
$1.54M Buy
74,510
+5,180
+7% +$107K ﹤0.01% 3441
2018
Q3
$1.51M Buy
69,330
+13,410
+24% +$292K ﹤0.01% 3596
2018
Q2
$853K Buy
55,920
+273
+0.5% +$4.16K ﹤0.01% 4035
2018
Q1
$1.1M Buy
55,647
+15,947
+40% +$314K ﹤0.01% 3785
2017
Q4
$621K Buy
+39,700
New +$621K ﹤0.01% 4149